Amgen报告收入丰厚,Vertex和Nomura等投资者的反应好坏参半。 Amgen reported strong earnings, with mixed reactions from investors like Vertex and Nomura.

机构投资者在Amgen Inc.上混杂在一起,Vertex规划伙伴有限责任有限公司的股份增加了9.9%,Nomura资产管理有限公司的股份减少了0.5%。 Institutional investors are mixed on Amgen Inc., with Vertex Planning Partners LLC increasing its stake by 9.9% and Nomura Asset Management Co. Ltd. reducing its holdings by 0.5%. Amgen报告收入丰厚,每股5.31美元,粗略估计增加27美分,红利收益3.11%。 Amgen reported strong earnings of $5.31 per share, beating estimates by 27 cents, and has a dividend yield of 3.11%. 该公司以Enbrel和Prolia等产品著称,市场上限为164.26亿美元,PE比率为40.50。 The company, known for products like Enbrel and Prolia, has a market cap of $164.26 billion and a PE ratio of 40.50.